Endoscopic ablation of Barrett's esophagus.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Barrett's esophagus is a premalignant lesion of the esophagus that arises as an abnormal tissue response to epithelial injury from gastroesophageal reflux. Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to prevent malignant transformation. Recently, combination therapy with pharmacologic or surgical control of acid reflux combined with endoscopic delivery of a mucosal injury appears to have the capability of reversing superficial Barrett's tissue, and perhaps deeper tissue as well. Whether Barrett's esophagus is cured and cancer/dysplasia prevented by these techniques will require long-term follow-up of these patients.

Original languageEnglish (US)
Pages (from-to)210-213
Number of pages4
JournalCurrent Gastroenterology Reports
Volume1
Issue number3
StatePublished - Jun 1999

Fingerprint

Barrett Esophagus
Wounds and Injuries
Gastroesophageal Reflux
Esophagus
Acids
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Endoscopic ablation of Barrett's esophagus. / Fennerty, M (Brian).

In: Current Gastroenterology Reports, Vol. 1, No. 3, 06.1999, p. 210-213.

Research output: Contribution to journalArticle

@article{be2a00dcc2a744eea66b0328817989f6,
title = "Endoscopic ablation of Barrett's esophagus.",
abstract = "Barrett's esophagus is a premalignant lesion of the esophagus that arises as an abnormal tissue response to epithelial injury from gastroesophageal reflux. Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to prevent malignant transformation. Recently, combination therapy with pharmacologic or surgical control of acid reflux combined with endoscopic delivery of a mucosal injury appears to have the capability of reversing superficial Barrett's tissue, and perhaps deeper tissue as well. Whether Barrett's esophagus is cured and cancer/dysplasia prevented by these techniques will require long-term follow-up of these patients.",
author = "Fennerty, {M (Brian)}",
year = "1999",
month = "6",
language = "English (US)",
volume = "1",
pages = "210--213",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Endoscopic ablation of Barrett's esophagus.

AU - Fennerty, M (Brian)

PY - 1999/6

Y1 - 1999/6

N2 - Barrett's esophagus is a premalignant lesion of the esophagus that arises as an abnormal tissue response to epithelial injury from gastroesophageal reflux. Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to prevent malignant transformation. Recently, combination therapy with pharmacologic or surgical control of acid reflux combined with endoscopic delivery of a mucosal injury appears to have the capability of reversing superficial Barrett's tissue, and perhaps deeper tissue as well. Whether Barrett's esophagus is cured and cancer/dysplasia prevented by these techniques will require long-term follow-up of these patients.

AB - Barrett's esophagus is a premalignant lesion of the esophagus that arises as an abnormal tissue response to epithelial injury from gastroesophageal reflux. Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to prevent malignant transformation. Recently, combination therapy with pharmacologic or surgical control of acid reflux combined with endoscopic delivery of a mucosal injury appears to have the capability of reversing superficial Barrett's tissue, and perhaps deeper tissue as well. Whether Barrett's esophagus is cured and cancer/dysplasia prevented by these techniques will require long-term follow-up of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0033139468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033139468&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 210

EP - 213

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 3

ER -